Advertisement

Topics

The Shifting Therapeutic Spectrum for Chronic Lymphocytic Leukemia

12:19 EDT 14 Jun 2019 | OncLive

For patients with chronic lymphocytic leukemia, including those with high-risk disease, the availability of novel targeted therapies and monoclonal antibodies offers an increased potential for improved outcomes.

Original Article: The Shifting Therapeutic Spectrum for Chronic Lymphocytic Leukemia

NEXT ARTICLE

More From BioPortfolio on "The Shifting Therapeutic Spectrum for Chronic Lymphocytic Leukemia"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Monoclonal antibodies MAbs
Monoclonal antibodies recognise and attach to specific proteins produced by cells.  Types of monoclonal antibodies used to treat cancer cells: Block cell dividing dividing signals Transport cancer drugs or radiation to cancer cells Tr...